Joan M. Bathon, MD

Expertise in: 
Rheumatoid Arthritis, Spondylitis & Psoriatic Arthritis, Gout
Board Certifications: 
Rheumatology, Internal Medicine
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Spondylitis & Psoriatic Arthritis, Rheumatoid Arthritis, Gout, Inflammatory Arthritis, Pseudo-Gout, Psoriatic Arthritis, Ankylosing Spondylitis

Academic Appointments

  • Professor of Medicine

Administrative Titles

  • Director, Division of Rheumatology

Joan M. Bathon, MD - Chief, Division of Rheumatology at CUMC

Dr. Bathon is the Director of the Division of Rheumatology at NewYork-Presbyterian Hospital/Columbia University Medical Center and Professor of Medicine at Columbia University College of Physicians and Surgeons. Previously, she was Deputy Director of the Division of Rheumatology and Director of the Arthritis Center at Johns Hopkins. Dr. Bathon is the Editor-in-Chief of the American College of Rheumatology journal, Arthritis and Rheumatism.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-4308

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Maryland School of Medicine
  • Internship: University of Maryland Medical Center
  • Residency: University of Maryland Medical Center
  • Fellowship: Johns Hopkins Hopital

Board Certifications

  • Rheumatology
  • Internal Medicine

Research

Dr. Bathon’s career has focused on understanding the pathogenesis and functional consequences of inflammation in Rheumatoid Arthritis (RA). Her group is particularly interested in understanding the effects of chronic rheumatoid inflammation on the extra-articular clinical phenotype of RA, as manifested by accelerated atherosclerosis and myocardial dysfunction. They have taken a combined epidemiological/ translational approach to address these questions, by establishing and following two RA cohorts over a prolonged period of time, and by combining sensitive imaging techniques with biomarker studies and clinical outcome assessments. In these studies they have comprehensively phenotyped the vascular beds (coronary, carotid, peripheral) of RA patients compared to controls, and identified risk factors for atherosclerosis and its progression. Current work focuses on defining prevalence and risk factors associated with vascular (aortic) inflammation, as well as myocardial inflammation, using state-of-the-art cardiac PET/CT scanning. Dr. Bathon is the PI on a longstanding R01 and co-PI on a current U01, and PI on several foundation grants. In addition, she has been the PI or co-investigator on many pivotal RA clinical trials, both industry and NIH sponsored. Dr. Bathon has authored over 160 manuscripts and book chapters. She served as Editor-in-Chief of Arthritis and Rheumatology from 2010-15. She is a standing member of the NIH-NIAMS Arthritis Musculoskeletal and Skin Diseases Clinical Trial Review Committee (AMSCT) study section, and has served on a variety of other NIH and foundation grant review study sections and as chair or member of several NIH sponsored DSMBs. She was a member of the Board of Directors of the American College of Rheumatology (ACR), and she is a past member of the FDA Arthritis Advisory Committee.

Grants

INFLAMMATION AND CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS (Federal Gov)

Jun 1 2017 - May 31 2022

BIOMARKERS CONSORTIUM TREATMENTS AGAINST RA AND EFFECT ON FDG PET-CT (TARGET BIOMARKER STUDY) (Private)

Sep 1 2017 - Aug 31 2018

PREDICTORS OF PROGRESSION OF ATHEROSCLEROSIS IN RA (Private)

Jul 1 2015 - Jun 30 2017

EVOLVING ADAPTIVE AND EFFECTOR MECHANISMS FROM PRE-RA THROUGH ESTABLISHED DISEASE (Federal Gov)

Jun 1 2016 - May 31 2017

TREATMENTS AGAINST RA AND EFFECT ON FDG PET/CT: THE TARGET TRIAL (Federal Gov)

Sep 28 2015 - Jun 30 2016

RHEUMATOID ARTHRITIS SYNOVIAL TISSUE NETWORK (REASON) (Federal Gov)

Sep 26 2014 - Aug 31 2015

PATHWAYS AND BIOMARKERS OF MYOCARDIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS (Private)

Jul 1 2013 - Jun 30 2015

EDITORIAL AGREEMENT WITH ACR TO SERVE AS EDITOR OF ARTHRITIS & RHEUMATISM (THE JOURNAL ) (Private)

Oct 1 2010 - Jun 30 2015

TREAT TO TARGET TO REDUCE ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS (Federal Gov)

Apr 1 2013 - Mar 31 2015

BIOMARKERS OF ENHANCED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS (Private)

Oct 1 2010 - Jun 30 2014

THE OMERAC RA BIODAM STUDY: PROSPECTIVE VALIDATION OF SOLUBL E BIOMARKERS AS PREDICTORS OF SRUCTURAL DAMAGE IN RHEUMATOID (Private)

Nov 10 2011 - Oct 31 2013

RA-ASSOCIATED LUNG DISEASE: USING QUANTITATIVE (Private)

Oct 1 2010 - Jun 30 2013